Back Daily Mail New immunotherapy drug becomes first ever to DOUBLE survival in lung cancer patients
Search Sections 19 Jul
Close
Advertisement
 New immunotherapy drug becomes first ever to DOUBLE survival in lung cancer patients 16 Apr 5:03pm

New immunotherapy drug becomes first ever to DOUBLE survival in lung cancer patients

Daily Mail
Merck's Keytruda, given with standard chemotherapy, cut in half the risk of dying or having the cancer worsen, compared to chemo alone after nearly one year.
Read full story
 Like Comment
Advertisement

Comments

No comments yet...
On the top

Date settings

Today is Thursday, July 19, 2018

+ 1 -
+ 1 -
+ 2016 -

Close

By using our website, you agree to the use of cookies as described in our cookie policy.

Accept

Daily Mail

Close